MKI67 and central nervous system cancer: Pathologic findings of recurrent tumors around the primary lesion and temporal lobe were consistent with those of grade III glioma with 30% of Ki67 index and grade II glioma with 5–10% of Ki67 index according to the WHO classification revised 4th edition, respectively (Fig. 3D).